B3GNTL1

Across TCGA pan-cancer cohorts, B3GNTL1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated B3GNTL1 data layer compared with 28 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher B3GNTL1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated B3GNTL1 expression acts as an unfavorable survival marker.

LUAD, UCEC, and LSCC are the cancer types where B3GNTL1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	0.295	0.819	.002	20	view →
UCEC	DFS	Median	III,IV	0.514	1.000	.025	16	view →
LSCC	OS	Tertile	III,IV	0.427	0.938	.014	12	view →
PDAC	OS	Quartile	III,IV	0.188	0.807	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

B3GNTL1–LUAD (OS)

Open the LUAD breakdown →